Gregory Licholai
Chief Tech/Sci/R&D Officer at ICON PUBLIC LIMITED COMPANY
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ciaran Murray | M | 61 | 19 years | |
| Bradley Campbell | M | 48 | 18 years | |
| Stephen Cutler | M | 63 | 13 years | |
| Simon Holmes | M | - | 19 years | |
| John Climax | M | 71 | 34 years | |
| Diarmaid Cunningham | M | 49 | 15 years | |
| Mike Raab Raab | M | 59 | 20 years | |
| Julie O'Neill | F | 58 | 5 years | |
| Tom O'Leary | M | - | 23 years | |
| Brendan Brennan | M | 45 | 18 years | |
| Joan Garahy | F | 61 | 7 years | |
| Eugene McCague | M | 65 | 7 years | |
| Linda Grais | M | 68 | 3 years | |
| Glenn Sblendorio | M | 68 | 18 years | |
| Margaret McGlynn | F | 64 | 15 years | |
| Rónán Murphy | M | 66 | 8 years | |
| Kate Haven | F | - | - | |
| Samir Shah | M | 49 | - | |
| Tami Klerr-Naivar | F | - | - | |
| George A. McMillan | M | - | 12 years | |
| Nuala Murphy | M | - | 12 years | |
| Jeffrey Castelli | M | - | 19 years | |
| Ryan Bethencourt | M | - | 12 years | |
| Andrew Garrett | M | - | 8 years | |
| Paul McCracken | M | - | 8 years | |
| Joe Cronin | M | - | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daphne Quimi | F | 58 | 18 years | |
| John M. Maslowski | M | 49 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 5 years |
| John M. McAdam | M | 49 | 4 years | |
| Donald Hayden | M | 68 | 12 years | |
| Gregory Wujek | M | 62 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 3 years |
| William Walmsley Hall | M | 74 | 9 years | |
| Michael Barrett | M | 81 | 6 years | |
| S. Schaeffer | F | 55 | 7 years | |
| Matt Patterson | M | 52 | 6 years | |
| James Topper | M | 62 | 11 years | |
| Gregory Mark Weinhoff | M | 53 | 7 years | |
| Alexander E. Barkas | M | 76 | - | |
| Mary K. Pendergast | F | 73 | 8 years | |
| Mohan Ganesan | M | 56 | 4 years | |
| Sol Barer | M | 76 | 8 years | |
| Kenneth W. Peist | M | 60 | 4 years | |
| Geoffrey P. Gilmore | M | 58 | 4 years | |
| Hugh Brady | M | 64 | 8 years | |
| Douglas A. Branch | M | - | - | |
| Bruce Ganem | M | - | 4 years | |
| John Koconis | M | 54 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 3 years |
| Amir Tavakkol | M | 69 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 1 years |
| John R. Kirk | M | 67 | - | |
| David J. Lockhart | M | 62 | 7 years | |
| James Dentzer | M | 57 | 3 years | |
| Colin Shannon | M | 65 | 12 years | |
| Joseph Michael Warusz | M | 67 | 1 years | |
| Norman Hardman | M | 78 | 2 years | |
| Enrique Dilone | M | 57 | 10 years | |
| Kenneth J. Valenzano | M | 56 | - | |
| Pol Boudes | M | 67 | 4 years | |
| Andrew Shenker | M | 69 | - | |
| Heather White | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 34 | 57.63% |
| Ireland | 25 | 42.37% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gregory Licholai
- Personal Network
